Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell turnover is a fundamental physiological process representing the balance between cell division (proliferation) and cell death (apoptosis) to maintain tissue homeostasis [1]. It is not a single molecular target, such as a receptor or enzyme, but rather a macroscopic biological outcome of complex signaling networks [2]. In healthy tissues, the rate of new cell production matches the rate of old cell loss, but this equilibrium is frequently disrupted in disease states [3]. For example, malignant tumors exhibit pathologically high cell turnover, while aging and degenerative diseases are characterized by a decline in the regenerative capacity of tissues [4]. Therapeutic interventions often aim to modulate cell turnover by targeting specific molecular drivers of the cell cycle or apoptotic machinery [5]. In clinical practice, the measurement of cell turnover is essential for assessing the efficacy and toxicity of treatments, particularly in oncology and dermatology [1, 3].
Modulation of cell turnover is achieved by inhibiting DNA synthesis, disrupting mitosis, or activating programmed cell death pathways in specific cell populations.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell turnover.